← back to search

Elana Shaw

National Institutes of Health · US
Area of research
Infectious Diseases · Genetics
Research interest
Research interests include COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Diabetes and associated disorders, and T-cell and B-cell Immunology.
h-index
15
citations
7,519
works
31
NIH funding
primary concept
Medicine
email

Recent publications

Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signature
Science Immunology 2025cited by 14position: middledoi
In Situ Biofilm Affinity-Based Protein Profiling Identifies the Streptococcal Hydrolase GbpB as the Target of a Carolacton-Inspired Chemical Probe
Journal of the American Chemical Society 2024cited by 9position: middledoi
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Proceedings of the National Academy of Sciences 2022cited by 188position: middledoi
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
Science Immunology 2021cited by 624position: middledoi
Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1
The Journal of Experimental Medicine 2021cited by 303position: middledoi
Neutralizing type‐I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID‐19
Immunology and Cell Biology 2021cited by 98position: middledoi
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Science 2020cited by 2,832position: middledoi
Virulence attenuating combination therapy: a potential multi-target synergy approach to treat<i>Pseudomonas aeruginosa</i>infections in cystic fibrosis patients
RSC Medicinal Chemistry 2020cited by 32position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

William M. Wuest · Emory University2 papers (2020–2024)Jean‐Laurent Casanova · Tehran University of Medical Sciences1 papers (2021–2021)Stephan A. Sieber · Technical University of Munich1 papers (2024–2024)Riccardo Castagnoli · University of Pavia1 papers (2021–2021)Andrea Biondi · Associazione Italiana Ematologia Oncologia Pediatrica1 papers (2021–2021)Steven M. Holland · Amsterdam University Medical Centers1 papers (2021–2021)Luisa Imberti · Rockefeller University1 papers (2021–2021)Lindsey B. Rosen · National Institute of Allergy and Infectious Diseases1 papers (2021–2021)Michael S. Abers · Kantonsspital Aarau1 papers (2021–2021)Hui Wu · University of Alabama at Birmingham1 papers (2024–2024) · 1 papers (2024–2024)Paolo Bonfanti · Azienda Ospedaliera Ospedale Civile di Legnano1 papers (2021–2021) · 1 papers (2024–2024)Hua Zhang · Ningbo University1 papers (2024–2024)Amy E. Solinski · Pennsylvania State University1 papers (2024–2024)Paul Bastard · Inserm1 papers (2021–2021)Helen C. Su · ActionAid1 papers (2021–2021)Julia E. Page · Massachusetts Institute of Technology1 papers (2024–2024)Michail S. Lionakis · National Institute of Allergy and Infectious Diseases1 papers (2021–2021)Amber M. Scharnow · Emory University1 papers (2024–2024)